Statement Of Financial Position [Abstract]

Xspray Pharma - Filing #702829

Concept	As at 2021-12-31	As at 2021-12-31	As at 2021-12-31	As at 2021-12-31	As at 2021-12-31	As at 2020-12-31	As at 2020-12-31	As at 2020-12-31	As at 2020-12-31	As at 2020-12-31	As at 2019-12-31	As at 2019-12-31	As at 2019-12-31	As at 2019-12-31	As at 2019-12-31
Statement of financial position [abstract]
Assets [abstract]
Property, plant and equipment	44 601 SEK	—	—	—	—	42 669 SEK	—	—	—	—	—	—	—	—	—
Right-of-use assets	3 526 SEK	—	—	—	—	5 207 SEK	—	—	—	—	—	—	—	—	—
Cash and cash equivalents	271 881 SEK	—	—	—	—	325 598 SEK	—	—	—	—	—	—	209 872 SEK	—	—
Assets	622 903 SEK	—	—	—	—	605 303 SEK	—	—	—	—	—	—	—	—	—
Equity and liabilities [abstract]
Equity [abstract]
Issued capital	20 680 SEK	—	—	—	—	18 893 SEK	—	—	—	—	—	—	—	—	—
Retained earnings	243 387 SEK	—	—	—	—	146 689 SEK	—	—	—	—	—	—	—	—	—
Other reserves	976,000 SEK	—	—	—	—	976,000 SEK	—	—	—	—	—	—	—	—	—
Equity attributable to owners of parent	591 752 SEK	—	—	—	—	582 587 SEK	—	—	—	—	—	—	—	—	—
Equity	591 752 SEK	243 387 SEK	976,000 SEK	813 483 SEK	20 680 SEK	582 587 SEK	18 893 SEK	146 689 SEK	709 407 SEK	976,000 SEK	94 279 SEK	976,000 SEK	373 715 SEK	450 266 SEK	16 752 SEK
Equity and liabilities	622 903 SEK	—	—	—	—	605 303 SEK	—	—	—	—	—	—	—	—	—